Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-01-05 @ 2:35 AM
Study NCT ID:
NCT02875067
Status:
TERMINATED
Last Update Posted:
2020-08-14
First Post:
2016-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma
Sponsor:
Organization: